JAX
Mouse Strain Datasheet - 005427
B6.129P2-Ccr5tm1Kuz/J
Also Known As: CCR5 KO
Absence of chemokine (C-C motif) receptor 5 in these knock-out mice affects immune and a number of other physiological responses. They are useful for widespread studies of innate immunity.
Donating Investigator
Israel F. Charo, Gladstone Inst of Cardiovascular Disease, UCSF
Genetic overview
| Genetic Background | Generation |
|---|---|
|
N11+F6
|
Ccr5tm1Kuz
| Allele Type | Gene Symbol | Gene Name |
|---|---|---|
| Targeted (Null/Knockout) | Ccr5 | chemokine (C-C motif) receptor 5 |
Research Applications
- Cancer Research
- Immunology, Inflammation and Autoimmunity Research
Detailed Description
At birth, mice homozygous for the targeted allele are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities. No transcript is detected in splenocytes or peritoneal macrophages. Thioglycollate-elicited peritoneal macrophages from homozygotes exhibit a delayed period before reaching peak mobilization (72 hours vs. 36 for wild type mice).
In an attempt to offer alleles on well-characterized or multiple genetic backgrounds, alleles are frequently moved to a genetic background different from that on which an allele was first characterized. This is the case for the strain 5427. It should be noted that the phenotype could vary from that originally described. We will modify the strain description if necessary as published results become available.
Development
A targeting vector containing a neomycin resistance gene was used to disrupt the single coding exon of the targeted gene. The construct was electroporated into 129P2/OlaHsd-derived E14TG2A embryonic stem (ES) cells. Correctly targeted ES cells were injected into C57BL/6J blastocysts to obtain chimeric animals. Mutant mice were maintained on a mixed C57BL/6 and 129P2 background for a period of time before they were donated to the Jackson Laboratory Induced Mutant Resource (IMR) by Dr. William Kuziel. Subsequently they were obtained by Dr. Israel Charo (Gladstone Institute of Cardiovascular Disease, UCSF) and backcrossed to C57BL/6 ten times before being imported once more into the IMR. The mice were crossed to C57BL/6J once upon arrival.
Control Suggestions
Selected References
- Kuziel WA; Dawson TC; Quinones M; Garavito E; Chenaux G; Ahuja SS; Reddick RL; Maeda N. 2003. CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice.. In: . . MGI: J:84243
Ccr5tm1Kuz
Allele Symbol: Ccr5tm1Kuz
| Allele Name | targeted mutation 1, William A Kuziel |
|---|---|
| Allele Type | Targeted (Null/Knockout) |
| Allele Synonym(s) | CCR5 KO; CCR5-; Cmkbr5tm1Kuz |
| Gene Symbol and Name | Ccr5, chemokine (C-C motif) receptor 5 |
| Gene Synonym(s) | CC-CKR-5; CCCKR5; CCR-5; CD195; CKR-5; CKR5; CMKBR5; Ckr5; Cmkbr5; Cmkbr5; IDDM22; chemokine (C-C) receptor 5 |
| Strain of Origin | 129P2/OlaHsd |
| Chromosome | 9 |
| Molecular Note | The exon containing the entire coding region was replaced with a neomycin resistance gene inserted by homologous recombination. |
| Mutations Made By | Dr. William Kuziel, Protein Design Laboratories |
Disease Terms
Research Areas By Genotype
This mouse can be used to support research in many areas including:
Genotype: Ccr5tm1Kuz related
- Cancer Research
- Growth Factors/Receptors/Cytokines
- Immunology, Inflammation and Autoimmunity Research
- Growth Factors/Receptors/Cytokines
Mammalian Phenotype Terms by Genotype
Genotype: Ccr5tm1Kuz/Ccr5tm1Kuz
B6.129P2-Ccr5tm1Kuz
behavior/neurological phenotype
- abnormal conditioned taste aversion behavior
- female mice develop a stronger ethanol-induced conditioned taste aversion compared with similarly treated wild-type mice (MGI Ref ID J:102583)
- behavior/neurological phenotype
- increased alcohol consumption
- in female but not male mice (MGI Ref ID J:102583)
- increased fluid intake
- of an ethanol, saccharin, or quinine solution (MGI Ref ID J:102583)
mortality/aging
- mortality/aging
- 40% mortality after kainic acid treatment (MGI Ref ID J:84037)
nervous system phenotype
- nervous system phenotype
vision/eye phenotype
- corneal vascularization
cardiovascular system phenotype
The following phenotype information is associated with a similar, but not exact match to this JAX® Mice strain
Genotype: Ccr5tm1Kuz/Ccr5tm1Kuz
involves: 129P2/OlaHsd * C57BL/6
immune system phenotype
- abnormal CD4-positive, alpha beta T cell morphology
- abnormal CD8-positive, alpha beta T cell morphology
- (MGI Ref ID J:110814)
- abnormal Kupffer cell morphology
- abnormal NK T cell physiology
- abnormal cytokine level
- mice expression one fifth the wild-type level of Ifng after day 3 and 7, while Il-4 is increased 75-fold and a 2-fold increase in Il-5 and -10 over wild-type (MGI Ref ID J:110814)
- decreased NK cell number
- 4 fold reduction of tumor infiltrating NK cells when mice are injected with B16 melanoma cells (MGI Ref ID J:135308)
- decreased microglial cell activation
- significant reduction in activated microglia in the hippocampus 8 hours after injection of beta amyloid 1-40 (MGI Ref ID J:153059)
- decreased susceptibility to induced colitis
- null mice show clinically less severe DSS-mediated colitis than wild-type or Ccr2-nulls (MGI Ref ID J:110814)
- decreased susceptibility to viral infection
- impaired macrophage chemotaxis
- increased NK T cell number
- null mice show a significant increase in NK 1.1+ T cells by day 3 and 7 of DSS-treatment; wild-type and Ccr2-null mice do not show as large of an increase (MGI Ref ID J:110814)
- increased susceptibility to fungal infection
- brains of infected mice develop loss of neural tissue integrity , and large amounts of extracellelular cryptococcal polysaccharide capsule (MGI Ref ID J:64293)
- by week 5 infected mice exhibit cryptococcal meningitis cranial swelling, ruffled fur, staggered gait, lethargy and unresponsiveness, and decreased limb function (MGI Ref ID J:64293)
- infected mice exhibit increased mononuclear cell recruitment to lungs, but not brain (MGI Ref ID J:64293)
- reduced survival following inoculation with Cryptococcus neoformans, 40% die by week 8 due to CNS infection (hydrocephalus) (MGI Ref ID J:64293)
behavior/neurological phenotype
- abnormal locomotor behavior
- mice show little reduction in activity with DSS treatment, unlike wild-type which become very lethargic with time (MGI Ref ID J:110814)
- abnormal long term spatial reference memory
- in a Morris water maze (MGI Ref ID J:153059)
- abnormal spatial learning
- improved learning performance in a Morris water maze after injection of beta amyloid 1-40 relative to controls (MGI Ref ID J:153059)
digestive/alimentary phenotype
- decreased susceptibility to induced colitis
- null mice show clinically less severe DSS-mediated colitis than wild-type or Ccr2-nulls (MGI Ref ID J:110814)
hematopoietic system phenotype
- abnormal CD4-positive, alpha beta T cell morphology
- abnormal CD8-positive, alpha beta T cell morphology
- (MGI Ref ID J:110814)
- abnormal Kupffer cell morphology
- abnormal NK T cell physiology
- decreased NK cell number
- 4 fold reduction of tumor infiltrating NK cells when mice are injected with B16 melanoma cells (MGI Ref ID J:135308)
- decreased microglial cell activation
- significant reduction in activated microglia in the hippocampus 8 hours after injection of beta amyloid 1-40 (MGI Ref ID J:153059)
- impaired macrophage chemotaxis
- increased NK T cell number
- null mice show a significant increase in NK 1.1+ T cells by day 3 and 7 of DSS-treatment; wild-type and Ccr2-null mice do not show as large of an increase (MGI Ref ID J:110814)
homeostasis/metabolism phenotype
- abnormal cytokine level
- mice expression one fifth the wild-type level of Ifng after day 3 and 7, while Il-4 is increased 75-fold and a 2-fold increase in Il-5 and -10 over wild-type (MGI Ref ID J:110814)
cellular phenotype
- impaired macrophage chemotaxis
nervous system phenotype
- abnormal astrocyte physiology
- significant reduction in activated astrocytes in the hippocampus 6 hours after injection of beta amyloid 1-40 (MGI Ref ID J:153059)
- abnormal glial cell physiology
- (MGI Ref ID J:153059)
- abnormal nervous system physiology
- decreased microglial cell activation
- significant reduction in activated microglia in the hippocampus 8 hours after injection of beta amyloid 1-40 (MGI Ref ID J:153059)
cardiovascular system phenotype
- abnormal Kupffer cell morphology
liver/biliary system phenotype
- abnormal Ito cell morphology
- complete suppression of hepatic stellate cell migration (MGI Ref ID J:152548)
- abnormal Kupffer cell morphology
- abnormal hepatocyte physiology
Genotype: Ccr5tm1Kuz/Ccr5tm1Kuz
involves: 129P2/OlaHsd
homeostasis/metabolism phenotype
- decreased susceptibility to injury
- after hypoxia exposure for 18 days, mice show lower right ventricular systolic pressure, less severe right ventricular hypertrophy, less muscularization of the distal pulmonary vessels with a smaller percentage of dividing Ki67-positive pulmonary vascular cells, lower counts of lung inflammatory monocytes and lower number of macrophages surrounding pulmonary vessels or present in the BAL fluid (MGI Ref ID J:227458)
cardiovascular system phenotype
- abnormal cardiovascular system physiology
- after hypoxia exposure for 18 days, distal pulmonary vessels exhibit less muscularization than wild-type mice, with a smaller percentage of dividing Ki67-positive pulmonary vascular cells (MGI Ref ID J:227458)
- abnormal heart size
- after hypoxia exposure for 18 days, right ventricular hypertrophy is less severe in mutants than in wild-type mice (MGI Ref ID J:227458)
- decreased right ventricle systolic pressure
- after hypoxia exposure for 18 days, right ventricular systolic pressure is lower in mutants than in wild-type mice (MGI Ref ID J:227458)
immune system phenotype
- decreased inflammatory response
- mice show lower counts of lung inflammatory monocytes than wild-type mice during both normoxia and hypoxia (MGI Ref ID J:227458)
- the number of macrophages surrounding pulmonary vessels or present in BAL fluid is not increased from normoxia to hypoxia as is seen in wild-type mice (MGI Ref ID J:227458)
References
- Kuziel WA; Dawson TC; Quinones M; Garavito E; Chenaux G; Ahuja SS; Reddick RL; Maeda N. 2003. CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice.. In: . . MGI: J:84243
Additional - Ccr5tm1Kuz related
- Abonia JP; Austen KF; Rollins BJ; Joshi SK; Flavell RA; Kuziel WA; Koni PA; Gurish MF. 2005. Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2.. In: . . MGI: J:98967
- Ajuebor MN; Aspinall AI; Zhou F; Le T; Yang Y; Urbanski SJ; Sidobre S; Kronenberg M; Hogaboam CM; Swain MG. 2005. Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells.. In: . . MGI: J:100869
- Ajuebor MN; Wondimu Z; Hogaboam CM; Le T; Proudfoot AE; Swain MG. 2007. CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitis.. In: . . MGI: J:122162
- Algood HM; Flynn JL. 2004. CCR5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration.. In: . . MGI: J:92716
- Aliberti J; Valenzuela JG; Carruthers VB; Hieny S; Andersen J; Charest H; Reis e Sousa C; Fairlamb A; Ribeiro JM; Sher A. 2003. Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells.. In: . . MGI: J:125439
- Ambati BK; Anand A; Joussen AM; Kuziel WA; Adamis AP; Ambati J. 2003. Sustained inhibition of corneal neovascularization by genetic ablation of CCR5.. In: . . MGI: J:118018
- Amsellem V; Lipskaia L; Abid S; Poupel L; Houssaini A; Quarck R; Marcos E; Mouraret N; Parpaleix A; Bobe R; Gary-Bobo G; Saker M; Dubois-Rande JL; Gladwin MT; Norris KA; Delcroix M; Combadiere C; Adnot S. 2014. CCR5 as a treatment target in pulmonary arterial hypertension.. In: . . MGI: J:227458
- Andres PG; Beck PL; Mizoguchi E; Mizoguchi A; Bhan AK; Dawson T; Kuziel WA; Maeda N; MacDermott RP; Podolsky DK; Reinecker HC. 2000. Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine.. In: . . MGI: J:110814
- Ank N; Petersen K; Malmgaard L; Mogensen SC; Paludan SR. 2005. Age-dependent role for CCR5 in antiviral host defense against herpes simplex virus type 2.. In: . . MGI: J:100102
- Araujo-Pires AC; Vieira AE; Francisconi CF; Biguetti CC; Glowacki A; Yoshizawa S; Campanelli AP; Trombone AP; Sfeir CS; Little SR; Garlet GP. 2015. IL-4/CCL22/CCR4 axis controls regulatory T-cell migration that suppresses inflammatory bone loss in murine experimental periodontitis.. In: . . MGI: J:233363
- Ariel A; Fredman G; Sun YP; Kantarci A; Van Dyke TE; Luster AD; Serhan CN. 2006. Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression.. In: . . MGI: J:113563
- Baba T; Nakamoto Y; Mukaida N. 2009. Crucial contribution of thymic Sirpalpha+ conventional dendritic cells to central tolerance against blood-borne antigens in a CCR2-dependent manner.. In: . . MGI: J:151848
- Baba T; Tanabe Y; Yoshikawa S; Yamanishi Y; Morishita S; Komatsu N; Karasuyama H; Hirao A; Mukaida N. 2016. MIP-1alpha/CCL3-expressing basophil-lineage cells drive the leukemic hematopoiesis of chronic myeloid leukemia in mice.. In: . . MGI: J:233075
- Belnoue E; Kayibanda M; Deschemin JC; Viguier M; Mack M; Kuziel WA; Renia L. 2003. CCR5 deficiency decreases susceptibility to experimental cerebral malaria.. In: . . MGI: J:83961
- Bierly AL; Shufesky WJ; Sukhumavasi W; Morelli AE; Denkers EY. 2008. Dendritic cells expressing plasmacytoid marker PDCA-1 are Trojan horses during Toxoplasma gondii infection.. In: . . MGI: J:142065
- Blednov YA; Bergeson SE; Walker D; Ferreira VM; Kuziel WA; Harris RA. 2005. Perturbation of chemokine networks by gene deletion alters the reinforcing actions of ethanol.. In: . . MGI: J:102583
- Bonfa G; Benevides L; Souza Mdo C; Fonseca DM; Mineo TW; Rossi MA; Silva NM; Silva JS; de Barros Cardoso CR. 2014. CCR5 controls immune and metabolic functions during Toxoplasma gondii infection.. In: . . MGI: J:223154
- Braunersreuther V; Zernecke A; Arnaud C; Liehn EA; Steffens S; Shagdarsuren E; Bidzhekov K; Burger F; Pelli G; Luckow B; Mach F; Weber C. 2007. Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice.. In: . . MGI: J:128063
- Camargo JF; Quinones MP; Mummidi S; Srinivas S; Gaitan AA; Begum K; Jimenez F; VanCompernolle S; Unutmaz D; Ahuja SS; Ahuja SK. 2009. CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation.. In: . . MGI: J:142900
- Carr DJ; Ash J; Lane TE; Kuziel WA. 2006. Abnormal immune response of CCR5-deficient mice to ocular infection with herpes simplex virus type 1.. In: . . MGI: J:135791
- Castellino F; Huang AY; Altan-Bonnet G; Stoll S; Scheinecker C; Germain RN. 2006. Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction.. In: . . MGI: J:107629
- Chang LY; Lin YC; Kang CW; Hsu CY; Chu YY; Huang CT; Day YJ; Chen TC; Yeh CT; Lin CY. 2012. The indispensable role of CCR5 for in vivo suppressor function of tumor-derived CD103+ effector/memory regulatory T cells.. In: . . MGI: J:189562
- Chang LY; Lin YC; Mahalingam J; Huang CT; Chen TW; Kang CW; Peng HM; Chu YY; Chiang JM; Dutta A; Day YJ; Chen TC; Yeh CT; Lin CY. 2012. Tumor-Derived Chemokine CCL5 Enhances TGF-beta-Mediated Killing of CD8+ T Cells in Colon Cancer by T-Regulatory Cells.. In: . . MGI: J:181486
- Chantakru S; Kuziel WA; Maeda N; Croy BA. 2001. A study on the density and distribution of uterine natural killer cells at mid pregnancy in mice genetically-ablated for CCR2, CCR 5 and the CCR5 receptor ligand, MIP-1alpha. In: . . MGI: J:66438
- Chatterjee S; Eby JM; Al-Khami AA; Soloshchenko M; Kang HK; Kaur N; Naga OS; Murali A; Nishimura MI; Le Poole IC; Mehrotra S. 2014. A quantitative increase in regulatory T cells controls development of vitiligo.. In: . . MGI: J:208054
- Chavez-Galan L; Vesin D; Segueni N; Prasad P; Buser-Llinares R; Blaser G; Pache JC; Ryffel B; Quesniaux VF; Garcia I. 2016. Tumor Necrosis Factor and Its Receptors Are Crucial to Control Mycobacterium bovis Bacillus Calmette-Guerin Pleural Infection in a Murine Model.. In: . . MGI: J:235296
- Chen Z; Yu S; Bakhiet M; Winblad B; Zhu J. 2003. The chemokine receptor CCR5 is not a necessary inflammatory mediator in kainic acid-induced hippocampal injury: evidence for a compensatory effect by increased CCR2 and CCR3.. In: . . MGI: J:84037
- Chiu BC; Freeman CM; Stolberg VR; Hu JS; Zeibecoglou K; Lu B; Gerard C; Charo IF; Lira SA; Chensue SW. 2004. Impaired lung dendritic cell activation in CCR2 knockout mice.. In: . . MGI: J:93675
- Chiu BC; Martin BE; Stolberg VR; Chensue SW. 2013. Cutting edge: Central memory CD8 T cells in aged mice are virtual memory cells.. In: . . MGI: J:207125
- Christmann BS; Moran JM; McGraw JA; Buller RM; Corbett JA. 2011. Ccr5 regulates inflammatory gene expression in response to encephalomyocarditis virus infection.. In: . . MGI: J:180065
- Cochain C; Rodero MP; Vilar J; Recalde A; Richart AL; Loinard C; Zouggari Y; Guerin C; Duriez M; Combadiere B; Poupel L; Levy BI; Mallat Z; Combadiere C; Silvestre JS. 2010. Regulation of monocyte subset systemic levels by distinct chemokine receptors controls post-ischaemic neovascularization.. In: . . MGI: J:182115
- Crawford A; Angelosanto JM; Nadwodny KL; Blackburn SD; Wherry EJ. 2011. A role for the chemokine RANTES in regulating CD8 T cell responses during chronic viral infection.. In: . . MGI: J:183343
- Cripps JG; Celaj S; Burdick M; Strieter RM; Gorham JD. 2012. Liver inflammation in a mouse model of Th1 hepatitis despite the absence of invariant NKT cells or the Th1 chemokine receptors CXCR3 and CCR5.. In: . . MGI: J:189898
- Daley D; Zambirinis CP; Seifert L; Akkad N; Mohan N; Werba G; Barilla R; Torres-Hernandez A; Hundeyin M; Mani VR; Avanzi A; Tippens D; Narayanan R; Jang JE; Newman E; Pillarisetty VG; Dustin ML; Bar-Sagi D; Hajdu C; Miller G. 2016. gammadelta T Cells Support Pancreatic Oncogenesis by Restraining alphabeta T Cell Activation.. In: . . MGI: J:236387
- Dawson TC; Beck MA; Kuziel WA; Henderson F; Maeda N. 2000. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus.. In: . . MGI: J:62675
- DePaolo RW; Lathan R; Karpus WJ. 2004. CCR5 regulates high dose oral tolerance by modulating CC chemokine ligand 2 levels in the GALT.. In: . . MGI: J:90955
- Dobaczewski M; Xia Y; Bujak M; Gonzalez-Quesada C; Frangogiannis NG. 2010. CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells.. In: . . MGI: J:160376
- Fadel SA; Bromley SK; Medoff BD; Luster AD. 2008. CXCR3-deficiency protects influenza-infected CCR5-deficient mice from mortality.. In: . . MGI: J:141370
- Fischer FR; Luo Y; Luo M; Santambrogio L; Dorf ME. 2001. RANTES-induced chemokine cascade in dendritic cells.. In: . . MGI: J:120465
- Fukuyama Y; Tokuhara D; Sekine S; Aso K; Kataoka K; Davydova J; Yamamoto M; Gilbert RS; Tokuhara Y; Fujihashi K; Kunisawa J; Yuki Y; Kiyono H; McGhee JR; Fujihashi K. 2013. Potential roles of CCR5(+) CCR6(+) dendritic cells induced by nasal ovalbumin plus Flt3 ligand expressing adenovirus for mucosal IgA responses.. In: . . MGI: J:199945
- Glass WG; Lim JK; Cholera R; Pletnev AG; Gao JL; Murphy PM. 2005. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection.. In: . . MGI: J:116832
- Gonzalez-Martin A; Gomez L; Lustgarten J; Mira E; Manes S. 2011. Maximal T Cell-Mediated Antitumor Responses Rely upon CCR5 Expression in Both CD4+ and CD8+ T Cells.. In: . . MGI: J:175447
- Goser S; Ottl R; Brodner A; Dengler TJ; Torzewski J; Egashira K; Rose NR; Katus HA; Kaya Z. 2005. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.. In: . . MGI: J:116910
- Gregg RK; Nichols L; Chen Y; Lu B; Engelhard VH. 2010. Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice.. In: . . MGI: J:159480
- Hallgren J; Jones TG; Abonia JP; Xing W; Humbles A; Austen KF; Gurish MF. 2007. Pulmonary CXCR2 regulates VCAM-1 and antigen-induced recruitment of mast cell progenitors.. In: . . MGI: J:130586
- Hamrah P; Yamagami S; Liu Y; Zhang Q; Vora SS; Lu B; Gerard CJ; Dana MR. 2007. Deletion of the chemokine receptor CCR1 prolongs corneal allograft survival.. In: . . MGI: J:123260
- Hardison JL; Wrightsman RA; Carpenter PM; Kuziel WA; Lane TE; Manning JE. 2006. The CC chemokine receptor 5 is important in control of parasite replication and acute cardiac inflammation following infection with Trypanosoma cruzi.. In: . . MGI: J:104277
- Herold S; von Wulffen W; Steinmueller M; Pleschka S; Kuziel WA; Mack M; Srivastava M; Seeger W; Maus UA; Lohmeyer J. 2006. Alveolar epithelial cells direct monocyte transepithelial migration upon influenza virus infection: impact of chemokines and adhesion molecules.. In: . . MGI: J:137974
- Hickman HD; Li L; Reynoso GV; Rubin EJ; Skon CN; Mays JW; Gibbs J; Schwartz O; Bennink JR; Yewdell JW. 2011. Chemokines control naive CD8+ T cell selection of optimal lymph node antigen presenting cells.. In: . . MGI: J:178641
- Huffnagle GB; McNeil LK; McDonald RA; Murphy JW; Toews GB; Maeda N; Kuziel WA. 1999. Cutting edge: Role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans.. In: . . MGI: J:64293
- Hugues S; Scholer A; Boissonnas A; Nussbaum A; Combadiere C; Amigorena S; Fetler L. 2007. Dynamic imaging of chemokine-dependent CD8(+) T cell help for CD8(+) T cell responses.. In: . . MGI: J:124274
- Ibrahim HM; Bannai H; Xuan X; Nishikawa Y. 2009. Toxoplasma gondii cyclophilin 18-mediated production of nitric oxide induces Bradyzoite conversion in a CCR5-dependent manner.. In: . . MGI: J:152248
- Islam SA; Chang DS; Colvin RA; Byrne MH; McCully ML; Moser B; Lira SA; Charo IF; Luster AD. 2011. Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cells.. In: . . MGI: J:168253
- Kalkonde YV; Shelton R; Villarreal M; Sigala J; Mishra PK; Ahuja SS; Barea-Rodriguez E; Moretti P; Ahuja SK. 2011. The CC chemokine receptor 5 regulates olfactory and social recognition in mice.. In: . . MGI: J:184043
- Kallikourdis M; Andersen KG; Welch KA; Betz AG. 2007. Alloantigen-enhanced accumulation of CCR5+ 'effector' regulatory T cells in the gravid uterus.. In: . . MGI: J:119074
- Kang SJ; Liang HE; Reizis B; Locksley RM. 2008. Regulation of hierarchical clustering and activation of innate immune cells by dendritic cells.. In: . . MGI: J:142395
- Kastenmuller W; Brandes M; Wang Z; Herz J; Egen JG; Germain RN. 2013. Peripheral Prepositioning and Local CXCL9 Chemokine-Mediated Guidance Orchestrate Rapid Memory CD8(+) T Cell Responses in the Lymph Node.. In: . . MGI: J:194479
- Kaul M; Ma Q; Medders KE; Desai MK; Lipton SA. 2007. HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection.. In: . . MGI: J:132342
- Kennedy A; Webb CD; Hill AA; Gruen ML; Jackson LG; Hasty AH. 2013. Loss of CCR5 results in glucose intolerance in diet-induced obese mice.. In: . . MGI: J:203854
- Khan IA; Thomas SY; Moretto MM; Lee FS; Islam SA; Combe C; Schwartzman JD; Luster AD. 2006. CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection.. In: . . MGI: J:141677
- Kitamura T; Qian BZ; Soong D; Cassetta L; Noy R; Sugano G; Kato Y; Li J; Pollard JW. 2015. CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages.. In: . . MGI: J:226363
- Kohlmeier JE; Cookenham T; Miller SC; Roberts AD; Christensen JP; Thomsen AR; Woodland DL. 2009. CXCR3 directs antigen-specific effector CD4+ T cell migration to the lung during parainfluenza virus infection.. In: . . MGI: J:152793
- Kohlmeier JE; Miller SC; Smith J; Lu B; Gerard C; Cookenham T; Roberts AD; Woodland DL. 2008. The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections.. In: . . MGI: J:137880
- Kohlmeier JE; Reiley WW; Perona-Wright G; Freeman ML; Yager EJ; Connor LM; Brincks EL; Cookenham T; Roberts AD; Burkum CE; Sell S; Winslow GM; Blackman MA; Mohrs M; Woodland DL. 2011. Inflammatory chemokine receptors regulate CD8(+) T cell contraction and memory generation following infection.. In: . . MGI: J:177600
- Kroetz DN; Deepe GS Jr. 2011. An aberrant thymus in CCR5-/- mice is coupled with an enhanced adaptive immune response in fungal infection.. In: . . MGI: J:173093
- Kroetz DN; Deepe GS Jr. 2010. CCR5 dictates the equilibrium of proinflammatory IL-17(+) and regulatory Foxp3(+) T cells in fungal infection.. In: . . MGI: J:160480
- Krohn R; Raffetseder U; Bot I; Zernecke A; Shagdarsuren E; Liehn EA; van Santbrink PJ; Nelson PJ; Biessen EA; Mertens PR; Weber C. 2007. Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice.. In: . . MGI: J:139837
- Lammermann T; Afonso PV; Angermann BR; Wang JM; Kastenmuller W; Parent CA; Germain RN. 2013. Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo.. In: . . MGI: J:198733
- Larena M; Regner M; Lobigs M. 2012. The chemokine receptor CCR5, a therapeutic target for HIV/AIDS antagonists, is critical for recovery in a mouse model of Japanese encephalitis.. In: . . MGI: J:191869
- Lee HK; Kim YG; Kim JS; Park EJ; Kim B; Park KH; Kang JS; Hong JT; Kim Y; Han SB. 2016. Cytokine-induced killer cells interact with tumor lysate-pulsed dendritic cells via CCR5 signaling.. In: . . MGI: J:232105
- Lee NJ; Choi DY; Song JK; Jung YY; Kim DH; Kim TM; Kim DJ; Kwon SM; Kim KB; Choi KE; Moon DC; Kim Y; Han SB; Hong JT. 2012. Deficiency of C-C chemokine receptor 5 suppresses tumor development via inactivation of NF-kappaB and inhibition of monocyte chemoattractant protein-1 in urethane-induced lung tumor model.. In: . . MGI: J:193223
- Lee YK; Kwak DH; Oh KW; Nam SY; Lee BJ; Yun YW; Kim YB; Han SB; Hong JT. 2009. CCR5 deficiency induces astrocyte activation, Abeta deposit and impaired memory function.. In: . . MGI: J:154425
- Li W; Ren G; Huang Y; Su J; Han Y; Li J; Chen X; Cao K; Chen Q; Shou P; Zhang L; Yuan ZR; Roberts AI; Shi S; Le AD; Shi Y. 2012. Mesenchymal stem cells: a double-edged sword in regulating immune responses.. In: . . MGI: J:204801
- Liu C; Lou Y; Lizee G; Qin H; Liu S; Rabinovich B; Kim GJ; Wang YH; Ye Y; Sikora AG; Overwijk WW; Liu YJ; Wang G; Hwu P. 2008. Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice.. In: . . MGI: J:135308
- Loyher PL; Rochefort J; Baudesson de Chanville C; Hamon P; Lescaille G; Bertolus C; Guillot-Delost M; Krummel MF; Lemoine FM; Combadiere C; Boissonnas A. 2016. CCR2 Influences T Regulatory Cell Migration to Tumors and Serves as a Biomarker of Cyclophosphamide Sensitivity.. In: . . MGI: J:237836
- Lynch EA; Heijens CA; Horst NF; Center DM; Cruikshank WW. 2003. Cutting edge: IL-16/CD4 preferentially induces Th1 cell migration: requirement of CCR5.. In: . . MGI: J:135472
- Ma B; Kang MJ; Lee CG; Chapoval S; Liu W; Chen Q; Coyle AJ; Lora JM; Picarella D; Homer RJ; Elias JA. 2005. Role of CCR5 in IFN-gamma-induced and cigarette smoke-induced emphysema.. In: . . MGI: J:104580
- Ma B; Liu W; Homer RJ; Lee PJ; Coyle AJ; Lora JM; Lee CG; Elias JA. 2006. Role of CCR5 in the pathogenesis of IL-13-induced inflammation and remodeling.. In: . . MGI: J:131183
- Mango RL; Wu QP; West M; McCook EC; Serody JS; van Deventer HW. 2014. C-C Chemokine Receptor 5 on Pulmonary Mesenchymal Cells Promotes Experimental Metastasis via the Induction of Erythroid Differentiation Regulator 1.. In: . . MGI: J:206600
- Mikhak Z; Farsidjani A; Luster AD. 2009. Endotoxin augmented antigen-induced Th1 cell trafficking amplifies airway neutrophilic inflammation.. In: . . MGI: J:149283
- Mikucki ME; Fisher DT; Matsuzaki J; Skitzki JJ; Gaulin NB; Muhitch JB; Ku AW; Frelinger JG; Odunsi K; Gajewski TF; Luster AD; Evans SS. 2015. Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints.. In: . . MGI: J:223004
- Molesworth-Kenyon S; Mates A; Yin R; Strieter R; Oakes J; Lausch R. 2005. CXCR3, IP-10, and Mig are required for CD4+ T cell recruitment during the DTH response to HSV-1 yet are independent of the mechanism for viral clearance.. In: . . MGI: J:101825
- Moore BB; Paine R rd; Christensen PJ; Moore TA; Sitterding S; Ngan R; Wilke CA; Kuziel WA; Toews GB. 2001. Protection from pulmonary fibrosis in the absence of CCR2 signaling.. In: . . MGI: J:82885
- Moreira AP; Cavassani KA; Massafera Tristao FS; Campanelli AP; Martinez R; Rossi MA; Silva JS. 2008. CCR5-Dependent Regulatory T Cell Migration Mediates Fungal Survival and Severe Immunosuppression.. In: . . MGI: J:131532
- Moreno C; Nicaise C; Gustot T; Quertinmont E; Nagy N; Parmentier M; Louis H; Deviere J. 2006. Chemokine receptor CCR5 deficiency exacerbates cerulein-induced acute pancreatitis in mice.. In: . . MGI: J:116897
- Motomura Y; Kanno S; Asano K; Tanaka M; Hasegawa Y; Katagiri H; Saito T; Hara H; Nishio H; Hara T; Yamasaki S. 2015. Identification of Pathogenic Cardiac CD11c+ Macrophages in Nod1-Mediated Acute Coronary Arteritis.. In: . . MGI: J:241622
- Nansen A; Christensen JP; Andreasen S SO; Bartholdy C; Christensen JE; Thomsen AR. 2002. The role of CC chemokine receptor 5 in antiviral immunity.. In: . . MGI: J:74713
- Pak-Wittel MA; Yang L; Sojka DK; Rivenbark JG; Yokoyama WM. 2013. Interferon-gamma mediates chemokine-dependent recruitment of natural killer cells during viral infection.. In: . . MGI: J:192522
- Park MH; Lee YK; Lee YH; Kim YB; Yun YW; Nam SY; Hwang SJ; Han SB; Kim SU; Hong JT. 2009. Chemokines released from astrocytes promote chemokine receptor 5-mediated neuronal cell differentiation.. In: . . MGI: J:154890
- Passos GF; Figueiredo CP; Prediger RD; Pandolfo P; Duarte FS; Medeiros R; Calixto JB. 2009. Role of the macrophage inflammatory protein-1alpha/CC chemokine receptor 5 signaling pathway in the neuroinflammatory response and cognitive deficits induced by beta-amyloid peptide.. In: . . MGI: J:153059
- Patterson SJ; Pesenacker AM; Wang AY; Gillies J; Mojibian M; Morishita K; Tan R; Kieffer TJ; Verchere CB; Panagiotopoulos C; Levings MK. 2016. T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression.. In: . . MGI: J:232426
- Peterson KE; Errett JS; Wei T; Dimcheff DE; Ransohoff R; Kuziel WA; Evans L; Chesebro B. 2004. MCP-1 and CCR2 contribute to non-lymphocyte-mediated brain disease induced by Fr98 polytropic retrovirus infection in mice: role for astrocytes in retroviral neuropathogenesis.. In: . . MGI: J:91095
- Potteaux S; Combadiere C; Esposito B; Lecureuil C; Ait-Oufella H; Merval R; Ardouin P; Tedgui A; Mallat Z. 2006. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice.. In: . . MGI: J:127996
- Quinones MP; Ahuja SK; Jimenez F; Schaefer J; Garavito E; Rao A; Chenaux G; Reddick RL; Kuziel WA; Ahuja SS. 2004. Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis.. In: . . MGI: J:89222
- Rahangdale S; Morgan R; Heijens C; Ryan TC; Yamasaki H; Bentley E; Sullivan E; Center DM; Cruikshank WW. 2006. Chemokine receptor CXCR3 desensitization by IL-16/CD4 signaling is dependent on CCR5 and intact membrane cholesterol.. In: . . MGI: J:129195
- Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ. 2005. MIP-1{alpha}[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-{alpha} and LTB4.. In: . . MGI: J:99288
- Ramos MV; Auvynet C; Poupel L; Rodero M; Mejias MP; Panek CA; Vanzulli S; Combadiere C; Palermo M. 2012. Chemokine receptor CCR1 disruption limits renal damage in a murine model of hemolytic uremic syndrome.. In: . . MGI: J:181964
- Repeke CE; Ferreira SB Jr; Claudino M; Silveira EM; de Assis GF; Avila-Campos MJ; Silva JS; Garlet GP. 2010. Evidences of the cooperative role of the chemokines CCL3, CCL4 and CCL5 and its receptors CCR1+ and CCR5+ in RANKL+ cell migration throughout experimental periodontitis in mice.. In: . . MGI: J:162053
- Robays LJ; Maes T; Lebecque S; Lira SA; Kuziel WA; Brusselle GG; Joos GF; Vermaelen KV. 2007. Chemokine receptor CCR2 but not CCR5 or CCR6 mediates the increase in pulmonary dendritic cells during allergic airway inflammation.. In: . . MGI: J:145267
- Robertson P; Means TK; Luster AD; Scadden DT. 2006. CXCR4 and CCR5 mediate homing of primitive bone marrow-derived hematopoietic cells to the postnatal thymus.. In: . . MGI: J:108468
- Salem ML; Al-Khami AA; El-Naggar SA; Diaz-Montero CM; Chen Y; Cole DJ. 2010. Cyclophosphamide induces dynamic alterations in the host microenvironments resulting in a Flt3 ligand-dependent expansion of dendritic cells.. In: . . MGI: J:159482
- Sapir Y; Vitenshtein A; Barsheshet Y; Zohar Y; Wildbaum G; Karin N. 2010. A Fusion Protein Encoding the Second Extracellular Domain of CCR5 Arrests Chemokine-Induced Cosignaling and Effectively Suppresses Ongoing Experimental Autoimmune Encephalomyelitis.. In: . . MGI: J:162542
- Sato N; Ahuja SK; Quinones M; Kostecki V; Reddick RL; Melby PC; Kuziel WA; Ahuja SS. 2000. CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation.. In: . . MGI: J:63491
- Sato N; Kuziel WA; Melby PC; Reddick RL; Kostecki V; Zhao W; Maeda N; Ahuja SK; Ahuja SS. 1999. Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice.. In: . . MGI: J:91256
- Sawai CM; Sisirak V; Ghosh HS; Hou EZ; Ceribelli M; Staudt LM; Reizis B. 2013. Transcription factor Runx2 controls the development and migration of plasmacytoid dendritic cells.. In: . . MGI: J:204587
- Schlecker E; Stojanovic A; Eisen C; Quack C; Falk CS; Umansky V; Cerwenka A. 2012. Tumor-Infiltrating Monocytic Myeloid-Derived Suppressor Cells Mediate CCR5-Dependent Recruitment of Regulatory T Cells Favoring Tumor Growth.. In: . . MGI: J:190855
- Schnickel GT; Bastani S; Hsieh GR; Shefizadeh A; Bhatia R; Fishbein MC; Belperio J; Ardehali A. 2008. Combined CXCR3/CCR5 Blockade Attenuates Acute and Chronic Rejection.. In: . . MGI: J:133385
- Schuh JM; Blease K; Hogaboam CM. 2002. The role of CC chemokine receptor 5 (CCR5) and RANTES/CCL5 during chronic fungal asthma in mice.. In: . . MGI: J:74277
- Seki E; De Minicis S; Gwak GY; Kluwe J; Inokuchi S; Bursill CA; Llovet JM; Brenner DA; Schwabe RF. 2009. CCR1 and CCR5 promote hepatic fibrosis in mice.. In: . . MGI: J:152548
- Sheahan T; Morrison TE; Funkhouser W; Uematsu S; Akira S; Baric RS; Heise MT. 2008. MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV.. In: . . MGI: J:162707
- Song JK; Park MH; Choi DY; Yoo HS; Han SB; Yoon do Y; Hong JT. 2012. Deficiency of C-C chemokine receptor 5 suppresses tumor development via inactivation of NF-kappaB and upregulation of IL-1Ra in melanoma model.. In: . . MGI: J:187266
- Souza AL; Souza PR; Pereira CA; Fernandes A; Guabiraba R; Russo RC; Vieira LQ; Correa A Jr; Teixeira MM; Negrao-Correa D. 2011. Experimental Infection with Schistosoma mansoni in CCR5-Deficient Mice Is Associated with Increased Disease Severity, as CCR5 Plays a Role in Controlling Granulomatous Inflammation.. In: . . MGI: J:170132
- Spranger S; Dai D; Horton B; Gajewski TF. 2017. Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.. In: . . MGI: J:242574
- Strutt TM; McKinstry KK; Dibble JP; Winchell C; Kuang Y; Curtis JD; Huston G; Dutton RW; Swain SL. 2010. Memory CD4+ T cells induce innate responses independently of pathogen.. In: . . MGI: J:160609
- TeKippe M; Harrison DE; Chen J. 2003. Expansion of hematopoietic stem cell phenotype and activity in Trp53-null mice.. In: . . MGI: J:115677
- Thapa M; Kuziel WA; Carr DJ. 2007. Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization.. In: . . MGI: J:121100
- Turner JE; Paust HJ; Bennstein SB; Bramke P; Krebs C; Steinmetz OM; Velden J; Haag F; Stahl RA; Panzer U. 2012. Protective role for CCR5 in murine lupus nephritis.. In: . . MGI: J:185452
- Turner JE; Paust HJ; Steinmetz OM; Peters A; Meyer-Schwesinger C; Heymann F; Helmchen U; Fehr S; Horuk R; Wenzel U; Kurts C; Mittrucker HW; Stahl RA; Panzer U. 2008. CCR5 deficiency aggravates crescentic glomerulonephritis in mice.. In: . . MGI: J:140716
- Turner SJ; Olivas E; Gutierrez A; Diaz G; Doherty PC. 2007. Disregulated influenza A virus-specific CD8+ T cell homeostasis in the absence of IFN-gamma signaling.. In: . . MGI: J:148590
- Tyner JW; Uchida O; Kajiwara N; Kim EY; Patel AC; O'Sullivan MP; Walter MJ; Schwendener RA; Cook DN; Danoff TM; Holtzman MJ. 2005. CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection.. In: . . MGI: J:102878
- Tzianabos AO; Holsti MA; Zheng XX; Stucchi AF; Kuchroo VK; Strom TB; Glimcher LH; Cruikshank WW. 2008. Functional Th1 cells are required for surgical adhesion formation in a murine model.. In: . . MGI: J:134863
- Valaperti A; Nishii M; Liu Y; Naito K; Chan M; Zhang L; Skurk C; Schultheiss HP; Wells GA; Eriksson U; Liu PP. 2013. Innate immune interleukin-1 receptor-associated kinase 4 exacerbates viral myocarditis by reducing CCR5(+) CD11b(+) monocyte migration and impairing interferon production.. In: . . MGI: J:219168
- Walker JK; Ahumada A; Frank B; Gaspard R; Berman K; Quackenbush J; Schwartz DA. 2006. Multistrain genetic comparisons reveal CCR5 as a receptor involved in airway hyperresponsiveness.. In: . . MGI: J:122615
- Warren GL; O'Farrell L; Summan M; Hulderman T; Mishra D; Luster MI; Kuziel WA; Simeonova PP. 2004. Role of CC chemokines in skeletal muscle functional restoration after injury.. In: . . MGI: J:95296
- Wildenberg ME; van Helden-Meeuwsen CG; van de Merwe JP; Moreno C; Drexhage HA; Versnel MA. 2008. Lack of CCR5 on dendritic cells promotes a proinflammatory environment in submandibular glands of the NOD mouse.. In: . . MGI: J:134455
- Wysocki CA; Jiang Q; Panoskaltsis-Mortari A; Taylor PA; McKinnon KP; Su L; Blazar BR; Serody JS. 2005. Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease.. In: . . MGI: J:123905
- Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR. 2005. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.. In: . . MGI: J:104985
- Yuan Q; Bromley SK; Means TK; Jones KJ; Hayashi F; Bhan AK; Luster AD. 2007. CCR4-dependent regulatory T cell function in inflammatory bowel disease.. In: . . MGI: J:125857
- Yun HM; Park KR; Park MH; Kim DH; Jo MR; Kim JY; Kim EC; Yoon do Y; Han SB; Hong JT. 2015. PRDX6 promotes tumor development via the JAK2/STAT3 pathway in a urethane-induced lung tumor model.. In: . . MGI: J:220347
- Yurchenko E; Tritt M; Hay V; Shevach EM; Belkaid Y; Piccirillo CA. 2006. CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence.. In: . . MGI: J:124636
- Zaidi MR; Davis S; Noonan FP; Graff-Cherry C; Hawley TS; Walker RL; Feigenbaum L; Fuchs E; Lyakh L; Young HA; Hornyak TJ; Arnheiter H; Trinchieri G; Meltzer PS; De Fabo EC; Merlino G. 2011. Interferon-gamma links ultraviolet radiation to melanomagenesis in mice.. In: . . MGI: J:172414
- Zaldivar MM; Berres ML; Sahin H; Nellen A; Heinrichs D; Schmitz P; Gassler N; Streetz KL; Trautwein C; Wasmuth HE. 2012. The chemokine receptor CXCR3 limits injury after acute toxic liver damage.. In: . . MGI: J:183489
- Zernecke A; Liehn EA; Gao JL; Kuziel WA; Murphy PM; Weber C. 2006. Deficiency in CCR5 but not CCR1 protects against neointima formation in atherosclerosis-prone mice: involvement of IL-10.. In: . . MGI: J:128843
- Zhang N; Schroppel B; Lal G; Jakubzick C; Mao X; Chen D; Yin N; Jessberger R; Ochando JC; Ding Y; Bromberg JS. 2009. Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response.. In: . . MGI: J:147032
- Zhao X; Sato A; Dela Cruz CS; Linehan M; Luegering A; Kucharzik T; Shirakawa AK; Marquez G; Farber JM; Williams I; Iwasaki A. 2003. CCL9 is secreted by the follicle-associated epithelium and recruits dome region Peyer's patch CD11b+ dendritic cells.. In: . . MGI: J:120209
- Zhong MX; Kuziel WA; Pamer EG; Serbina NV. 2004. Chemokine receptor 5 is dispensable for innate and adaptive immune responses to Listeria monocytogenes infection.. In: . . MGI: J:87864
- de Lemos C; Christensen JE; Nansen A; Moos T; Lu B; Gerard C; Christensen JP; Thomsen AR. 2005. Opposing effects of CXCR3 and CCR5 deficiency on CD8+ T cell-mediated inflammation in the central nervous system of virus-infected mice.. In: . . MGI: J:107278
- van Deventer HW; O'Connor W Jr; Brickey WJ; Aris RM; Ting JP; Serody JS. 2005. C-C chemokine receptor 5 on stromal cells promotes pulmonary metastasis.. In: . . MGI: J:97833
- van Deventer HW; Palmieri DA; Wu QP; McCook EC; Serody JS. 2013. Circulating Fibrocytes Prepare the Lung for Cancer Metastasis by Recruiting Ly-6C+ Monocytes Via CCL2.. In: . . MGI: J:195511
- van Deventer HW; Wu QP; Bergstralh DT; Davis BK; O'Connor BP; Ting JP; Serody JS. 2008. C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9.. In: . . MGI: J:137381